AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32064691 — intervention group
Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 40
Study 34860318 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipatasertib plus paclitaxel
Number of subjects: 222
Study 34860318 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 222
Study 34860318 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipatasertib
Number of subjects: 222
Study 34860318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 35599000 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (3.75 mg/day)
Number of subjects: 230
Study 35599000 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75 mg/day)
Number of subjects: 230
Study 35599000 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 230
Study 35599000 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 230
Study 33874660 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole placement into gingival pockets; General therapy with Calcemin
Number of subjects: 68
Study 33874660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of metronidazole and Eplan; General therapy with alendronate and alphacalcidolum
Number of subjects: 68
Study 33874660 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplan and alendronate and alphacalcidolum based medicines
Number of subjects: 68
Study 33874660 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 68
Study 35141811 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam 0.5 mg 30 min before bedtime for 4 weeks
Number of subjects: 34
Study 35141811 — intervention group
Group type: COMPARATOR
Intervention: Prolonged-release melatonin 2 mg 30 min before bedtime for 4 weeks
Number of subjects: 34
Study 34423487 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF-ET in patients with uterus didelphys
Number of subjects: 83
Study 32668499 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTA) injection
Number of subjects: 30
Study 32668499 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (control)
Number of subjects: 30
Study 36435664 — intervention group
Group type: EXPERIMENTAL
Intervention: CUdent/extra soft
Number of subjects: 30
Study 36435664 — intervention group
Group type: EXPERIMENTAL
Intervention: CUdent/soft
Number of subjects: 30
Study 36435664 — intervention group
Group type: COMPARATOR
Intervention: Colgate
Number of subjects: 30
Study 36435664 — intervention group
Group type: COMPARATOR
Intervention: GoodAge
Number of subjects: 30
Study 33626291 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD‐TDV booster (n=89)
Number of subjects: 118
Study 33626291 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=29)
Number of subjects: 118
Study 32687081 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy monitoring (Group II)
Number of subjects: 60
Study 32687081 — intervention group
Group type: COMPARATOR
Intervention: Conventional clinical monitoring (Group I)
Number of subjects: 60
Study 33249884 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-Orthodox Jewish women
Number of subjects: 239
Study 34535631 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal retraining with movement
Number of subjects: 113
Study 34535631 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal retraining without movement
Number of subjects: 113
Study 34535631 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal retraining (both conditions combined)
Number of subjects: 113
Study 34535631 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal retraining (with and without movement)
Number of subjects: 113
Study 34535631 — intervention group
Group type: COMPARATOR
Intervention: Thought suppression
Number of subjects: 113
Study 34535631 — intervention group
Group type: COMPARATOR
Intervention: Merely observing a picture
Number of subjects: 113
Study 33181641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral reflective training (CBRT)
Number of subjects: 167
Study 33181641 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 167
Study 34582670 — intervention group
Group type: COMPARATOR
Intervention: CCRT with weekly cisplatin followed by observation (arm A)
Number of subjects: 259
Study 34582670 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT with paclitaxel plus carboplatin every 4 weeks for 3 cycles (arm B)
Number of subjects: 259
Study 32989541 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 190
Study 32989541 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 190
Study 33198876 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff pressure at 30 cmH2O
Number of subjects: 90
Study 33198876 — intervention group
Group type: COMPARATOR
Intervention: Cuff pressure at 20 cmH2O
Number of subjects: 90
Study 33198876 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff pressure at 25 cmH2O
Number of subjects: 90
Study 35352605 — intervention group
Group type: EXPERIMENTAL
Intervention: VR 'walk in the woods'
Number of subjects: 24
Study 35352605 — intervention group
Group type: EXPERIMENTAL
Intervention: VR 'forest of focus'
Number of subjects: 24
Study 35352605 — intervention group
Group type: COMPARATOR
Intervention: Computer screen 'forest of focus'
Number of subjects: 24
Study 35352605 — intervention group
Group type: COMPARATOR
Intervention: Computer screen 'walk in the woods'
Number of subjects: 24
Study 34281467 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 34281467 — intervention group
Group type: COMPARATOR
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 0
Study 34281467 — intervention group
Group type: COMPARATOR
Intervention: Metformin or ILI
Number of subjects: 0
Study 32978029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided puncture
Number of subjects: 194
Study 32978029 — intervention group
Group type: COMPARATOR
Intervention: Anatomical landmark-guided puncture
Number of subjects: 194
Study 34655087 — intervention group
Group type: COMPARATOR
Intervention: Propofol (2 mg/kg intravenously, maintained at 5 mg/kg/h)
Number of subjects: 90
Study 34655087 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose remimazolam tosylate (0.25 mg/kg intravenously, maintained at 0.48 mg/kg/h)
Number of subjects: 90
Study 34655087 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose remimazolam tosylate (0.25 mg/kg intravenously, maintained at 0.6 mg/kg/h)
Number of subjects: 90
Study 34655087 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam tosylate (both doses)
Number of subjects: 90
Study 34655087 — intervention group
Group type: COMPARATOR
Intervention: Both remimazolam tosylate and propofol
Number of subjects: 90
Study 32789656 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro Seal® (PS)
Number of subjects: 20
Study 32789656 — intervention group
Group type: EXPERIMENTAL
Intervention: Opal® Seal™ (OS)
Number of subjects: 20
Study 32789656 — intervention group
Group type: COMPARATOR
Intervention: Both sealants (PS and OS)
Number of subjects: 20
Study 32331087 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg SPN-812
Number of subjects: 310
Study 32331087 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg SPN-812
Number of subjects: 310
Study 32331087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study 36105449 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone treatment
Number of subjects: 200
Study 36105449 — intervention group
Group type: COMPARATOR
Intervention: Mailuoning injection treatment
Number of subjects: 200
Study 32961410 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (24 IU intranasal)
Number of subjects: 193
Study 32961410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 32967701 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower weightbearing ankle dorsiflexion range of motion
Number of subjects: 188
Study 32967701 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher FPI scores (more pronated foot posture)
Number of subjects: 188
Study 32967701 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater midfoot mobility
Number of subjects: 188
Study 34459569 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt substitute (75% sodium chloride and 25% potassium chloride by mass)
Number of subjects: 20995
Study 34459569 — intervention group
Group type: COMPARATOR
Intervention: Regular salt (100% sodium chloride)
Number of subjects: 20995
Study 35414566 — intervention group
Group type: EXPERIMENTAL
Intervention: HUG-5 tool administered periodically in an outpatient clinic using a semi-automated workflow
Number of subjects: 0
Study 35414566 — intervention group
Group type: EXPERIMENTAL
Intervention: HUG-5 and GlauQoL-17
Number of subjects: 0
Study 35414566 — intervention group
Group type: COMPARATOR
Intervention: Frequency of calls
Number of subjects: 0
Study 34332762 — intervention group
Group type: EXPERIMENTAL
Intervention: EIT‐4‐BPSD implementation strategy
Number of subjects: 553
Study 34332762 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 553
Study 33686027 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (SH)
Number of subjects: 30
Study 33686027 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (CS)
Number of subjects: 30
Study 33741314 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Plastic Stents (MPS)
Number of subjects: 164
Study 33741314 — intervention group
Group type: COMPARATOR
Intervention: Fully Covered Self-Expanding Metal Stent (FCSEMS)
Number of subjects: 164
Study 32526771 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental oxygen uptake test on a treadmill before starting (neo-)adjuvant treatment and an exercise intervention
Number of subjects: 535
Study 32526771 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut-points for variables associated with the test leader's evaluation
Number of subjects: 535
Study 32526771 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal heart rate and oxygen uptake plateau
Number of subjects: 535
Study 37728450 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of bupivacaine with 75 mcg of clonidine
Number of subjects: 64
Study 37728450 — intervention group
Group type: COMPARATOR
Intervention: 20 mg of bupivacaine
Number of subjects: 64
Study 33893705 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-based TIVA
Number of subjects: 130
Study 33893705 — intervention group
Group type: COMPARATOR
Intervention: Control (inhaled sevoflurane anaesthesia)
Number of subjects: 130
Study 34022945 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game training without seeing myosignals
Number of subjects: 28
Study 34022945 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual myosignal training
Number of subjects: 28
Study 34022945 — intervention group
Group type: COMPARATOR
Intervention: Control group using touchpad
Number of subjects: 28
Study 34022945 — intervention group
Group type: EXPERIMENTAL
Intervention: Both experimental groups
Number of subjects: 28
Study 34022945 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically relevant measure 'accuracy'
Number of subjects: 28
Study 34022945 — intervention group
Group type: EXPERIMENTAL
Intervention: Feature of the myosignals 'variation in phasing'
Number of subjects: 28
Study 32202505 — intervention group
Group type: EXPERIMENTAL
Intervention: MamaKits online (5-week guided internet intervention)
Number of subjects: 159
Study 32202505 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control condition)
Number of subjects: 159
Study 32202505 — intervention group
Group type: EXPERIMENTAL
Intervention: MamaKits online
Number of subjects: 159
Study 36317958 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor (bolus and infusion for 2 hours)
Number of subjects: 20
Study 36317958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36317958 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 20
Study 36317958 — intervention group
Group type: COMPARATOR
Intervention: Cangrelor and Placebo
Number of subjects: 20
Study 33864607 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment, n = 6
Number of subjects: 14
Study 33864607 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment, n = 8
Number of subjects: 14
Study 35314958 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training Group (RTG) - two sessions/week for 12 weeks plus instructions to undertake ≥ 10,000 steps/day
Number of subjects: 60
Study 35314958 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - ≥ 10,000 steps/day only
Number of subjects: 60
Study 34068824 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent drinking (especially heavy drinking)
Number of subjects: 12937
Study 34068824 — intervention group
Group type: EXPERIMENTAL
Intervention: Average amount of alcohol consumed weekly (in frequent drinkers with obesity)
Number of subjects: 12937
Study 34068824 — intervention group
Group type: COMPARATOR
Intervention: Never or infrequent drinkers
Number of subjects: 12937
Study 34068824 — intervention group
Group type: COMPARATOR
Intervention: Frequent drinkers
Number of subjects: 12937
Study 36000743 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft palate closure at 4 months and hard palate closure at 12 months (Arm A)
Number of subjects: 79
Study 36000743 — intervention group
Group type: COMPARATOR
Intervention: Closure of both the soft and hard palate at 12 months (Arm C)
Number of subjects: 79
Study 36000743 — intervention group
Group type: EXPERIMENTAL
Intervention: Both surgical methods
Number of subjects: 79
Study 34366153 — intervention group
Group type: EXPERIMENTAL
Intervention: Henagliflozin 10 mg in the fasted condition
Number of subjects: 12
Study 34366153 — intervention group
Group type: EXPERIMENTAL
Intervention: Henagliflozin 10 mg in the fed condition
Number of subjects: 12
Study 34366153 — intervention group
Group type: COMPARATOR
Intervention: Comparison of fasted vs fed conditions
Number of subjects: 12
Study 34366153 — intervention group
Group type: EXPERIMENTAL
Intervention: Henagliflozin in fasted state
Number of subjects: 12
Study 34366153 — intervention group
Group type: EXPERIMENTAL
Intervention: Henagliflozin in fed state
Number of subjects: 12
Study 34366153 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal prior to henagliflozin administration
Number of subjects: 12
Study 34366153 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mass balance of henagliflozin
Number of subjects: 12
Study 33546681 — intervention group
Group type: COMPARATOR
Intervention: Alcohol dependence vignette
Number of subjects: 1414
Study 33546681 — intervention group
Group type: COMPARATOR
Intervention: Depression vignette
Number of subjects: 1414
Study 34212234 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser (980 nm)
Number of subjects: 50
Study 34212234 — intervention group
Group type: COMPARATOR
Intervention: Topical corticosteroid (0.1% triamcinolone acetonide)
Number of subjects: 50
Study 34023739 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 81
Study 34023739 — intervention group
Group type: EXPERIMENTAL
Intervention: Group walking
Number of subjects: 81
Study 34023739 — intervention group
Group type: COMPARATOR
Intervention: Usual care control (UC)
Number of subjects: 81
Study 32586526 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 250
Study 32586526 — intervention group
Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 250
Study 34128236 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool Little Kids parenting group programme
Number of subjects: 545
Study 34128236 — intervention group
Group type: COMPARATOR
Intervention: Usual care access to available support services
Number of subjects: 545
Study 33846016 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis
Number of subjects: 15703
Study 33846016 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis (type 1 cancers)
Number of subjects: 15703
Study 33846016 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic statins after diagnosis
Number of subjects: 15703
Study 33846016 — intervention group
Group type: EXPERIMENTAL
Intervention: New use of statins after diagnosis
Number of subjects: 15703
Study 33846016 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing number of statin prescriptions
Number of subjects: 15703
Study 35178234 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM acupuncture
Number of subjects: 84
Study 35178234 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation training (Control)
Number of subjects: 84
Study 34114493 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellular medicine trials (including stem cell therapy) for COVID-19
Number of subjects: 0
Study 34114493 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 cellular medicine trials
Number of subjects: 0
Study 35775704 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional photodynamic therapy (c-PDT)
Number of subjects: 50
Study 35775704 — intervention group
Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (dl-PDT)
Number of subjects: 50
Study 32840059 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D visualization helmet (3DVH)
Number of subjects: 184
Study 32840059 — intervention group
Group type: COMPARATOR
Intervention: Standard Galilean microscope (GM)
Number of subjects: 184
Study 33739874 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 140
Study 33739874 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 140
Study 33739874 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise
Number of subjects: 140
Study 33739874 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 140
Study 32555096 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-composite suture anchor (glycolic polylactic acid anchors, beta‐tricalcium phosphate and calcium sulphate)
Number of subjects: 33
Study 32555096 — intervention group
Group type: COMPARATOR
Intervention: Open-construct (PEEK) suture anchor
Number of subjects: 33
Study 36121143 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic high-volume HIIT (H-HIIT)
Number of subjects: 31
Study 36121143 — intervention group
Group type: COMPARATOR
Intervention: Normoxic HIIT (N-HIIT)
Number of subjects: 31
Study 34326476 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 32469304 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine and piracetam (10 mL of a solution containing L-carnitine 100 mg/mL + piracetam 80 mg/mL)
Number of subjects: 61
Study 32469304 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 61
Study 32469304 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine and piracetam
Number of subjects: 61
Study 35386730 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behaviour Therapy for PTSD (DBT-PTSD)
Number of subjects: 14
Study 36221089 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-free home (SFH) intervention delivered in mosques
Number of subjects: 900
Study 36221089 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor air quality (IAQ) feedback
Number of subjects: 900
Study 36221089 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 900
Study 32255488 — intervention group
Group type: EXPERIMENTAL
Intervention: SER-109
Number of subjects: 89
Study 32255488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 33027167 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty or hemiarthroplasty
Number of subjects: 1441
Study 35533601 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and Brief Intervention (SBI)
Number of subjects: 84
Study 35533601 — intervention group
Group type: COMPARATOR
Intervention: General advice (Control)
Number of subjects: 84
Study 34858929 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAD program training
Number of subjects: 0
Study 33109679 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydroxyurea 10-20 mg/kg daily for 6 months
Number of subjects: 0
Study 33109679 — intervention group
Group type: COMPARATOR
Intervention: Placebo identical in size, shape and colour to hydroxyurea
Number of subjects: 0
Study 34271424 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible stimulation
Number of subjects: 10
Study 34271424 — intervention group
Group type: COMPARATOR
Intervention: Standard stimulation
Number of subjects: 10
Study 33139837 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D reconstruction, point to point mirroring and merging of the 3D created volumes
Number of subjects: 10
Study 35880150 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making tool
Number of subjects: 53
Study 35880150 — intervention group
Group type: COMPARATOR
Intervention: No shared decision-making tool
Number of subjects: 53
Study 35880150 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 53
Study 32562077 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD + EMD
Number of subjects: 80
Study 32562077 — intervention group
Group type: COMPARATOR
Intervention: OFD
Number of subjects: 80
Study 35043755 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated online intergenerational friendship (participants revealed being an older adult, age 65)
Number of subjects: 0
Study 35043755 — intervention group
Group type: COMPARATOR
Intervention: Control condition (participants did not reveal their age)
Number of subjects: 0
Study 34340641 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Health Climate Scale (FHC Scale)
Number of subjects: 789
Study 33066130 — intervention group
Group type: EXPERIMENTAL
Intervention: Octagon warning
Number of subjects: 1997
Study 33066130 — intervention group
Group type: EXPERIMENTAL
Intervention: Circle warning
Number of subjects: 1997
Study 33066130 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangle warning
Number of subjects: 1997
Study 33066130 — intervention group
Group type: COMPARATOR
Intervention: Control label (barcode)
Number of subjects: 1997
Study 35361632 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of methylprednisolone intravenously for three consecutive days
Number of subjects: 304
Study 35361632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study 34605100 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine administration
Number of subjects: 29